Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2025 Earnings Conference Call May 5, 2025 8:30 AM ET
Company Participants
Chris Ward – Senior Director, Investor Relations
Mojdeh Poul – President and Chief Executive Officer
Lea Knight – Executive Vice President and Chief Financial Officer
Conference Call Participants
Young Li – Jefferies
Iseult McMahon – BTIG
Vik Chopra – Wells Fargo
Lilia-Celine Lozada – JPMorgan
Ravi Misra – Truist Securities
Anthony Occhiogrosso – Citi
Jayson Bedford – Raymond James
Craig Bijou – Bank of America Securities
Operator
Good day and thank you for standing by. Welcome to the Integra LifeSciences First Quarter 2025 Financial Results Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your host today, Chris Ward, Senior Director of Investor Relations. Please go ahead.
Chris Ward
Good morning and thank you for joining the Integra LifeSciences first quarter 2025 earnings conference call. With me on the call are Mojdeh Poul, President and Chief Executive Officer; and Lea Knight, Chief Financial Officer.
Earlier this morning, we issued a press release announcing our first quarter 2025 financial results. The release and corresponding earnings presentation, which we will reference during the call, are available at integralife.com under Investors, Events and Presentations in the file named, First Quarter 2025 Earnings Call Presentation.
Before we begin, I want to remind you that many of the statements made during this call may be considered forward-looking. Factors that could cause actual results to differ materially are discussed in the company’s Exchange Act reports filed with the SEC and in the release.
Also in our prepared remarks, we will reference reported and organic revenue growth. Organic
#Integra #LifeSciences #Holdings #Corporation #IART #Earnings #Call #Transcript